In the early stages of the COVID-19 pandemic, a study by Huang et al. revealed that elevated circulating levels of IL-6 were associated with clinical deterioration and the need for critical care support, suggesting that IL-6 could potentially serve as a target for intervention [4, 32]. This evidence concerns the gene IL6 and COVID-19.